Federation des caisses Desjardins du Quebec’s Utah Medical Products UTMD Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.9K	Hold	225	–	–	﹤0.01%	2207
2025 Q4	$12.6K	Hold	225	–	–	﹤0.01%	2181
2025 Q3	$14.2K	Hold	225	–	–	﹤0.01%	2141
2025 Q2	$12.8K	Hold	225	–	–	﹤0.01%	1947
2025 Q1	$12.6K	Hold	225	–	–	﹤0.01%	1883
2024 Q4	$13.8K	Hold	225	–	–	﹤0.01%	1770
2024 Q3	$15.1K	Hold	225	–	–	﹤0.01%	1754
2024 Q2	$15K	Hold	225	–	–	﹤0.01%	1692
2024 Q1	$16K	Hold	225	–	–	﹤0.01%	1698
2023 Q4	$18.9K	Hold	225	–	–	﹤0.01%	1592
2023 Q3	$19.4K	Hold	225	–	–	﹤0.01%	1585
2023 Q2	$21K	Hold	225	–	–	﹤0.01%	1564
2023 Q1	$21.3K	Hold	225	–	–	﹤0.01%	1554
2022 Q4	$22.6K	Hold	225	–	–	﹤0.01%	1645
2022 Q3	$19.2K	Hold	225	–	–	﹤0.01%	1748
2022 Q2	$19.3K	Hold	225	–	–	﹤0.01%	1762
2022 Q1	$20.2K	Hold	225	–	–	﹤0.01%	1826
2021 Q4	$22.5K	Sell	225 -100	-31%	-$10.2K	﹤0.01%	1799
2021 Q3	$30.2K	Buy	325 +100	+44%	+$8.83K	﹤0.01%	1734
2021 Q2	$19.1K	Hold	225	–	–	﹤0.01%	1876
2021 Q1	$19.5K	Hold	225	–	–	﹤0.01%	1810
2020 Q4	$19K	Hold	225	–	–	﹤0.01%	1753
2020 Q3	$18K	Hold	225	–	–	﹤0.01%	1525
2020 Q2	$19.9K	Hold	225	–	–	﹤0.01%	1440
2020 Q1	$21.2K	Hold	225	–	–	﹤0.01%	1484
2019 Q4	$24.3K	Hold	225	–	–	﹤0.01%	1685
2019 Q3	$21.6K	Hold	225	–	–	﹤0.01%	1660
2019 Q2	$21.5K	Hold	225	–	–	﹤0.01%	1681
2019 Q1	$19.9K	Hold	225	–	–	﹤0.01%	1515
2018 Q4	$18.7K	Hold	225	–	–	﹤0.01%	1488
2018 Q3	$21.2K	Sell	225 -200	-47%	-$19.1K	﹤0.01%	1540
2018 Q2	$46.8K	Hold	425	–	–	﹤0.01%	1361
2018 Q1	$42K	Hold	425	–	–	﹤0.01%	1376
2017 Q4	$34.6K	Hold	425	–	–	﹤0.01%	1438
2017 Q3	$31.3K	Hold	425	–	–	﹤0.01%	1420
2017 Q2	$30.8K	Hold	425	–	–	﹤0.01%	1485
2017 Q1	$26.5K	Buy	+425	New	+$26.8K	﹤0.01%	1250

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's UTMD Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Utah Medical Products (UTMD) position steady in Q1 2026 at 225 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2207.

Federation des caisses Desjardins du Quebec first reported a position in UTMD in Q1 2017 and has held it in 37 quarters since. The position peaked at $46.8K in Q2 2018. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

Federation des caisses Desjardins du Quebec held 225 shares of Utah Medical Products worth $13.9K as of Q1 2026.
Federation des caisses Desjardins du Quebec left its Utah Medical Products share count unchanged in Q1 2026.
Utah Medical Products made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2207 holding.
Federation des caisses Desjardins du Quebec first reported a position in Utah Medical Products in Q1 2017 and has held it in 37 quarters since.
Federation des caisses Desjardins du Quebec's Utah Medical Products position peaked at $46.8K in Q2 2018.
119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.